Portfolio company
Humedics
Germany
Raised
Undisclosed
Latest stage
Series B
Rounds recorded
3 · 3 undisclosed
Backed by
4 investors
Sectors
About
The company develops liver function capacity tests for clinicians managing patients in liver surgery, transplantation, hepatology and oncology.
SourceFunding history · 3
Similar companies
Humedics
Humedics develops non-invasive breath analysis diagnostic systems for measuring liver function capacity in patients with liver diseases and cancer.
Glycotest
This company develops non-invasive blood tests for the early detection of liver cancers and fibrosis-cirrhosis in patients with chronic liver disease.
Aged Diagnostics
The company develops non-invasive blood tests to diagnose liver disease and stage fibrosis for healthcare providers and patients.
Hepta Bio
This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.
Oncoustics
This company develops AI-powered software that analyses raw ultrasound signals for non-invasive liver disease diagnostics and tissue characterisation for clinics and pharmaceutical partners.
OrganOx
This medical technology company manufactures normothermic machine perfusion devices for preserving and assessing donor livers used by transplant surgeons and hospitals.
VISCIENT
This company develops novel therapies and drug discovery platforms using three-dimensional human tissue models to treat liver diseases for biopharmaceutical partners.
Levels Diagnostics
This company develops protein biomarker tests to help medical professionals diagnose infectious diseases and detect early-stage liver cancer from blood samples.
